| Primary |
| Type 1 Diabetes Mellitus |
32.6% |
| Type 2 Diabetes Mellitus |
28.1% |
| Product Used For Unknown Indication |
14.6% |
| Diabetes Mellitus |
6.7% |
| Drug Use For Unknown Indication |
6.7% |
| Diabetes Prophylaxis |
2.2% |
| Drug Abuse |
2.2% |
| Gestational Diabetes |
2.2% |
| Heparin Neutralisation Therapy |
2.2% |
| Hypertension |
2.2% |
|
| Drug Exposure During Pregnancy |
11.4% |
| Intra-uterine Death |
8.6% |
| Panniculitis |
8.6% |
| Suicide Attempt |
8.6% |
| Weight Increased |
8.6% |
| Injection Site Abscess |
5.7% |
| Locked-in Syndrome |
5.7% |
| Pruritus Generalised |
5.7% |
| Respiratory Distress |
5.7% |
| Abortion Spontaneous |
2.9% |
| Anaphylactic Shock |
2.9% |
| Chest Discomfort |
2.9% |
| Drug Ineffective |
2.9% |
| Gangrene |
2.9% |
| Gestational Hypertension |
2.9% |
| Lip Swelling |
2.9% |
| Neonatal Diabetes Mellitus |
2.9% |
| Pre-eclampsia |
2.9% |
| Pregnancy |
2.9% |
| Pulmonary Embolism |
2.9% |
|
| Secondary |
| Type 1 Diabetes Mellitus |
36.5% |
| Type 2 Diabetes Mellitus |
14.9% |
| Drug Use For Unknown Indication |
12.9% |
| Gestational Diabetes |
7.1% |
| Product Used For Unknown Indication |
6.7% |
| Hypertension |
5.9% |
| Diabetes Mellitus |
3.9% |
| Diabetes Mellitus Insulin-dependent |
2.0% |
| Rheumatoid Arthritis |
1.6% |
| Angina Pectoris |
0.8% |
| Arrhythmia |
0.8% |
| Coronary Artery Disease |
0.8% |
| Gout |
0.8% |
| Heparin Neutralisation Therapy |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Insulin-requiring Type Ii Diabetes Mellitus |
0.8% |
| Migraine |
0.8% |
| Oral Contraception |
0.8% |
| Prophylaxis |
0.8% |
| Respiratory Distress |
0.8% |
|
| Pregnancy |
25.0% |
| Small For Dates Baby |
9.4% |
| Weight Increased |
9.4% |
| Ketonuria |
7.8% |
| Injection Site Reaction |
6.3% |
| Emergency Care |
4.7% |
| Subarachnoid Haemorrhage |
4.7% |
| Caesarean Section |
3.1% |
| Delirium |
3.1% |
| Intra-uterine Death |
3.1% |
| Neonatal Respiratory Distress Syndrome |
3.1% |
| Pre-eclampsia |
3.1% |
| Premature Baby |
3.1% |
| Pulse Absent |
3.1% |
| Sensation Of Foreign Body |
3.1% |
| Chest Discomfort |
1.6% |
| Craniosynostosis |
1.6% |
| Drug Ineffective |
1.6% |
| Exposure During Pregnancy |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.9% |
| Diabetes Mellitus |
15.5% |
| Product Used For Unknown Indication |
15.1% |
| Hypertension |
11.7% |
| Type 2 Diabetes Mellitus |
6.1% |
| Type 1 Diabetes Mellitus |
4.9% |
| Prophylaxis |
3.7% |
| Renal Transplant |
3.0% |
| Pain |
2.6% |
| Pneumonia |
2.4% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Atrial Fibrillation |
1.9% |
| Hypercholesterolaemia |
1.7% |
| Hyperglycaemia |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Hyperlipidaemia |
1.4% |
| Multiple Sclerosis |
1.4% |
| Cardiac Failure |
1.3% |
| Depression |
1.3% |
| Crohn's Disease |
1.1% |
|
| Renal Failure Acute |
21.6% |
| Vomiting |
13.9% |
| Sepsis |
8.8% |
| Thrombocytopenia |
8.2% |
| Pyrexia |
4.6% |
| Weight Decreased |
4.1% |
| International Normalised Ratio Increased |
3.6% |
| Malaise |
3.1% |
| Myocardial Infarction |
3.1% |
| Off Label Use |
3.1% |
| Renal Failure |
3.1% |
| Rhabdomyolysis |
3.1% |
| Transplant Rejection |
3.1% |
| Urinary Tract Infection |
3.1% |
| Gastrointestinal Haemorrhage |
2.6% |
| Syncope |
2.6% |
| Deafness Bilateral |
2.1% |
| Duodenal Ulcer Haemorrhage |
2.1% |
| Fatigue |
2.1% |
| Febrile Neutropenia |
2.1% |
|
